The Pros And Cons Of Smoking Marijuana

The hypothesis of cannabis as a starting drug is now rejected by science as a myth. Of course, smoking Marijuana is not entirely risk-free. Excessive consumption can lead to respiratory problems or difficulties in coping with everyday life. In very rare cases, cannabis can trigger a latent psychosis. However, numerous studies prove that cannabis is substantially less harmful than alcohol and tobacco. According to official data, in contrast to hemp, these legal drugs have claimed more than 100,000 deaths in the United States alone. On the other hand, not a single death is documented as a result of cannabis consumption.
Veterans with post-traumatic stress disorder aka “PTSD”, cancer patients, kids and adults with epilepsy, and others who were
in related distresses would finally have the opportunity to turn to medicinal marijuana for treatment. This need is especially critical for the Department of Veterans Affairs aka VA, where outdated attitudes and regulations do a great disservice to our nation’s returning warriors who need and deserve this kind of help. Even though the percentage of Americans who consume marijuana has doubled since 2002, nevertheless, hemp is still being demonized by politics, and invests billions of dollars each year in the pursuit of its consumers. This essay will go over recent scientific research supporting strong evidence for medical benefits as well as research statistics opposing medical marijuana legalization and its medical value and how likely it is for the proposed bill to pass in the Congress. The future of tomorrow cannot succeed with the mistakes of yesterday!

Cannabis is increasingly used in medicine.
It is an effective alternative to pharmaceutical products for many diseases, also because the risks and side effects are comparatively low. The risks and problems that the consumption of hemp or other drugs can bring with them are legal and illegal, and depend on various factors, such as: type of drug, consumption behavior and social environment. A prohibition adds further problems: For the consumer, it means going into a criminal milieu, not having any information about the quality of drugs and being criminalized. For the society, the prohibition mainly means more crime and thus high costs for the police and the judiciary. Faced with the increasing medical use of cannabis and the trend to decriminalize both medical and non-medical use, one might suspect that the benefits of the drug are sufficiently known. But scientific research is still in children's shoes. In studies, the active ingredients of cannabis show promising pharmacological effects. Still, it will take some time to make sure that their knowledge is useful. The medicinal use of marijuana in the form of dried leaves and flowers of the Cannabis sativa cannabis and products derived therefrom dates back thousands of years. In Chinese medicine, medical marijuana use goes back to the 2727 BC. Cannabis came to Europe for the first time around the year 1840 and established itself in the medical world of Europe and America in the decades afterwards. At that time there were over
30 different preparations with cannabis as an active ingredient. Based on medical advice, they were used against all kinds of ailments, such as menstrual problems, asthma, cough, insomnia, migraine or inflammation of the throat, but also in obstetrical support for labor pains or opium withdrawal. . In the early 20th century, cannabis was increasingly used in Western medicine. However, the popularity of marijuana as a medicine did not last long. There were difficulties in ensuring the quality and development of suitable dosage forms. The efficacy was unreliable, and there were side effects. The knowledge about how marijuana works has grown considerably over the last decades again. Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) - the so-called cannabinoids - are responsible for its effect, which in the human body have their own receptor system. The human organism also produces a corporeal version of cannabinoids, the so-called endocannabinoids. This explains why receptors occur virtually anywhere in the body, but especially in the brain. There are essentially two types of cannabinoid receptors: CB1 and CB2. CB1 receptors are predominantly located in the areas of the brain and spinal cord, which influence well-being, memory, pain, concentration and coordination. The most important cannabinoid in marijuana is THC. It acts on the CB1 receptors and leads to the psychoactive effects that are responsible for the marijuana's effects. The other effective cannabinoid in marijuana is CBD. It acts on the CB2 receptors, which mainly occur on cells of the immune system, for example in the spleen, the white blood cells and the tonsils. CBD is not psychoactive and may even inhibit the psychoactive effect of THC. Medical marijuana can be significant in a variety of ways. The long-term effects on mortality and morbidity risk are still unclear. However, there is an increased risk of triggering psychotic and psychiatric disorders, habituation and dependency effects, as well as the risk of misuse. Another potential risk is accidents caused by cognitive impairments and driving under "drug influence". Unlike the breath alcohol test, there are currently no reliable measuring devices on the market that can be used to determine if the person driving is under the influence of cannabis. Yet, the effects of tobacco are far better explored and the relative risk of marijuana smoking is still to be determined by extensive research. Nevertheless, there is evidence of a damaging effect on the respiratory tract. Some clinical studies are linked to lung cancer, but this is discussed inconsistently. In the pharmaceutical industry, research is being carried out on more and more effective ways of administration, both in terms of uniform quality, impact and safety.

A standout amongst swift policy moves in the United States history is the latest communal recognition, government legalization, and broad utilization of medicinal marijuana. In more than twenty states, lawmakers have abolished fines for medicinal marijuana possession and permitted dispensaries to operate as a legitimate business. This current legal alteration has followed although the federal administration is continuing to classify marijuana as a Schedule I controlled substance. This classification places marijuana in a similar classification as heroin and cocaine, medicines without presently recognized health significance.
The outlook of this bill has a combination of cosponsors, 3 Republicans and 14 Democrats. It has been handed over to the Senate Judiciary Committee but has not yet been voted on.

This is the actual outline of the proposed Congress Bill S. 683. The bill sponsors argue that the bill would help patients as a medical treatment without having to worry about legal repercussions. It would also downgrade the drug from being a Schedule I to a Schedule II drug.

This article emphasizes why the CARERS is so important for marijuana policy reform.
CARERS is in search for to cover two of the substantial challenges, which are Veteran's access to marijuana treatment and banking affairs. This article breaks Bill S. 683 into sections and analyses each. It addresses pretty much every part in the state-government strife of therapeutic marijuana laws. This is a peer reviewed publication. This article surveys preclinical and clinical data, and contentions encompassing the utilization of medical marijuana for the treatment of epilepsy and presents a defense that the longing to disconnect and treat with pharmaceutical drugs might not be such an inferior treatment option compared to marijuana plant extract, specifically CBD. This is also a peer reviewed publication. It touches on how the CARERS Act would prohibit federal banking regulations from penalizing banks for accepting customer accounts from marijuana related businesses. It also talks about how this bill would further encourage medical research related to medical marijuana treatment. It also touches on how the VA healthcare providers need to start recommending marijuana treatment as suitable. This is another peer reviewed publication which touches on scientific data that bolsters the part of endocannabinoid system related to seizures, and how this treatment has shown positive signs in controlling seizure episodes in animals as well as human beings who suffer from catastrophic
seizures.